CongressBuys

Congress trades in Regencell Bioscience Holdings Limited (RGC)

Healthcare · Drug Manufacturers - Specialty & Generic

1 member of Congress has disclosed 2 trades in Regencell Bioscience Holdings Limited (RGC) since 2017: 0 buys and 2 sales. The most recent was disclosed on Dec 21, 2017.

Trades disclosed
2
Members trading
1
Buys / sells
0 / 2
Reported value
$1M–$2M

Who traded RGC

All trades

From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.